GR1008227B - Stable pharmaceutical composition of a benzimidazole photon pump inhibitor and method for the preparation thereof - Google Patents

Stable pharmaceutical composition of a benzimidazole photon pump inhibitor and method for the preparation thereof

Info

Publication number
GR1008227B
GR1008227B GR20130100254A GR20130100254A GR1008227B GR 1008227 B GR1008227 B GR 1008227B GR 20130100254 A GR20130100254 A GR 20130100254A GR 20130100254 A GR20130100254 A GR 20130100254A GR 1008227 B GR1008227 B GR 1008227B
Authority
GR
Greece
Prior art keywords
benzimidazole
preparation
pharmaceutical composition
pump inhibitor
stable pharmaceutical
Prior art date
Application number
GR20130100254A
Other languages
Greek (el)
Inventor
Ευαγγελος Ανδρεα Καραβας
Original Assignee
"Φαρματεν Α.Β.Ε.Ε.",
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Φαρματεν Α.Β.Ε.Ε.", filed Critical "Φαρματεν Α.Β.Ε.Ε.",
Priority to GR20130100254A priority Critical patent/GR1008227B/en
Publication of GR1008227B publication Critical patent/GR1008227B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to the implementation of a method of manufacturing solid dosage forms suitable for parenteral administration after reconstitution in sterile solvent comprising benzimidazole proton pump inhibitors, in particular esomeprazole or pharmaceutical acceptable salt thereof.
GR20130100254A 2013-04-24 2013-04-24 Stable pharmaceutical composition of a benzimidazole photon pump inhibitor and method for the preparation thereof GR1008227B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20130100254A GR1008227B (en) 2013-04-24 2013-04-24 Stable pharmaceutical composition of a benzimidazole photon pump inhibitor and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100254A GR1008227B (en) 2013-04-24 2013-04-24 Stable pharmaceutical composition of a benzimidazole photon pump inhibitor and method for the preparation thereof

Publications (1)

Publication Number Publication Date
GR1008227B true GR1008227B (en) 2014-06-16

Family

ID=51360450

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100254A GR1008227B (en) 2013-04-24 2013-04-24 Stable pharmaceutical composition of a benzimidazole photon pump inhibitor and method for the preparation thereof

Country Status (1)

Country Link
GR (1) GR1008227B (en)

Similar Documents

Publication Publication Date Title
PH12016500072A1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
PH12015502002A1 (en) Tripeptide epoxy ketone protease inhibitors
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
DK3146515T3 (en) SYSTEM AND METHOD OF PHARMACEUTICAL STORAGE, DELIVERY AND ADMINISTRATION
EA201491285A1 (en) IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID
EA201491671A1 (en) Heterocyclic Compounds
MX338515B (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors.
NZ760790A (en) Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
IN2015KN00005A (en)
MX2016004492A (en) Inhibitors of human immunodeficiency virus replication.
JO3326B1 (en) Tripeptide Epoxy Ketone Protease Inhibitors
PH12015502755A1 (en) Insulin glargine / lixisenatide fixed ratio formulation
UA115357C2 (en) Pyridin-4-yl derivatives
UA116053C2 (en) Use of benzimidazole-proline derivatives
IN2013MU03583A (en)
MX2016004741A (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent.
EP4360621A3 (en) Formulations of bendamustine
WO2014153495A3 (en) Novel stat3 inhibitors
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
IN2014MU01042A (en)
MX2016003522A (en) Quinazoline derivatives and their use as dna methyltransferase inhibitors.
WO2014145314A3 (en) Methods and compositions for gamma-glutamyl cycle modulation
CY1121708T1 (en) INDANYL UREA COMPOUNDS WHICH INHIBIT P38 MAP KINASE
GR1008227B (en) Stable pharmaceutical composition of a benzimidazole photon pump inhibitor and method for the preparation thereof
IN2013MU03428A (en)

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140718